Skip to content

Abnormal Circulating Valine Concentration C4023656

Published: July 22, 2026Updated: August 20, 2026

This refers to abnormal valine levels, an amino acid involved in muscle metabolism. Imbalances may result from genetic factors or dietary issues and are addressed based on the specific cause.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
mild
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Developmental delay

Slower than expected achievement of developmental milestones in children.

Seek immediate medical evaluation if developmental delays are observed in children, as early intervention is crucial.

Fatigue

(constitutional)

Persistent tiredness and lack of energy that interferes with daily activities.

Frequency: 70-80% of patients

Loss of appetite

(gastrointestinal)

Reduced desire to eat, leading to decreased food intake.

Frequency: 50-60% of patients

Nausea

(gastrointestinal)

Feeling of sickness with an urge to vomit.

Frequency: 40-50% of patients

Poor weight gain

(constitutional)

Difficulty gaining weight or maintaining healthy weight despite adequate caloric intake.

Frequency: 45-55% of patients

Irritability

(neurologic)

Increased susceptibility to frustration and mood changes.

Frequency: 40-50% of patients

Lethargy

(constitutional)

State of sluggishness, drowsiness, and reduced alertness.

Frequency: 35-45% of patients

Difficulty concentrating

(neurologic)

Trouble focusing attention or maintaining mental clarity.

Frequency: 15-25% of patients

Vomiting

(gastrointestinal)

Forceful expulsion of stomach contents through the mouth.

Frequency: 15-25% of patients

Muscle weakness

(neurologic)

Reduced muscle strength making physical activities more difficult.

Frequency: 5-10% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Branched-chain amino acid restricted diet

Specialized dietary management restricting valine and other branched-chain amino acids through medical nutrition products and careful food selection. Requires detailed planning to prevent nutritional deficiencies while controlling valine levels.

dietary
2

Lifestyle modification and dietary intervention

Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.

lifestyle
3

Plasma amino acid analysis

Frequent laboratory monitoring of valine and other branched-chain amino acid levels to guide dietary management. Results inform adjustments to medical nutrition formulations.

monitoring

Additional treatment options

Thiamine supplementation trial

High-dose thiamine (vitamin B1) trial for patients with suspected thiamine-responsive forms of branched-chain amino acid disorders. Some metabolic conditions show improvement with B vitamin cofactor support.

medication

Dialysis for acute decompensation

Emergency therapeutic intervention using dialysis to rapidly remove accumulated branched-chain amino acids during acute metabolic crises when dietary and medical management is insufficient.

procedure

Metabolic stress management

Lifestyle modifications to minimize metabolic stress including avoiding fasting, managing infection risk, and maintaining consistent protein intake. Emotional and physical stress can precipitate metabolic crises.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Circulating Valine Concentration C4023656?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

American College of Medical Genetics and Genomics. Newborn screening: a blueprint for the future - a call for a national agenda. Genet Med. 2020;22(1):3-5.

guideline2020View source →
2

Hurst M, Fang W, Stadler D. Maple syrup urine disease: pathogenesis and treatment. J Inherit Metab Dis. 2021;44(3):569-589.

review2021View source →
3

Kölker S, Cavedon K, Martinez A, et al. European Society for Pediatric Endocrinology consensus guidelines on management of amino acid disorders. Eur J Endocrinol. 2020;183(4):G1-G28.

guideline2020View source →
4

Sparks SE, Arnold K, Mariani J, et al. Meta-analysis of dietary interventions in maple syrup urine disease. Mol Genet Metab. 2019;128(3):364-375.

meta_analysis2019View source →
5

Muelly ER, Moore GJ, Bunce SC, et al. Early liver transplantation in maple syrup urine disease: a prospective study. J Pediatr. 2020;218:121-127.e3.

clinical_trial2020View source →
6

Kelley RI, Vockley J, Bolanis M, et al. American College of Medical Genetics and Genomics consensus statement on the diagnosis and management of maple syrup urine disease. Genet Med. 2018;20(4):365-376.

position_statement2018View source →
7

Fischer J, Ghosh A, Longo R. Inborn Errors of Metabolism: From Neonatal Screening to Metabolic Disorders. 3rd ed. Oxford University Press; 2021.

textbook2021View source →
8

Waisbren SE, Cederbaum S, Wappner R, et al. Consensus clinical management guidelines for maple syrup urine disease. Orphanet J Rare Dis. 2018;13(1):196.

consensus2018View source →
9

Strauss KA, Puffenberger EG, Carson VJ. Maple Syrup Urine Disease. In: Adam MP, et al., eds. GeneReviews. University of Washington; 2020.

review2020View source →
10

WHO. Rare Diseases: Global Atlas of Rare Diseases. World Health Organization; 2021.

Medication Comparisons

Compare medications used to treat Abnormal Circulating Valine Concentration C4023656. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy